Loading…
Experimental pancreatitis results in increased blood-brain barrier permeability in rats: A potential role of MCP-1
OBJECTIVE: To measure the changes of blood‐brain barrier (BBB) permeability in rats with acute pancreatitis (AP) and to investigate the role of monocyte chemoattractant protein (MCP)‐1 expression in this alteration. METHODS: Rat model of severe acute pancreatitis (SAP) and mild acute pancreatitis...
Saved in:
Published in: | Journal of digestive diseases 2012-03, Vol.13 (3), p.179-185 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4838-65dd5cbde96d6dd9f05477baaf55efb07139b0fad2fbed943e0e106a8012cc933 |
---|---|
cites | cdi_FETCH-LOGICAL-c4838-65dd5cbde96d6dd9f05477baaf55efb07139b0fad2fbed943e0e106a8012cc933 |
container_end_page | 185 |
container_issue | 3 |
container_start_page | 179 |
container_title | Journal of digestive diseases |
container_volume | 13 |
creator | DING, Zhen LIU, Jun LIN, Rong HOU, Xiao Hua |
description | OBJECTIVE: To measure the changes of blood‐brain barrier (BBB) permeability in rats with acute pancreatitis (AP) and to investigate the role of monocyte chemoattractant protein (MCP)‐1 expression in this alteration.
METHODS: Rat model of severe acute pancreatitis (SAP) and mild acute pancreatitis (MAP) was induced by pancreatic duct infusion of 5% and 0.5% sodium choleate, respectively, and a saline infusion was used in the control. The severity of AP was evaluated by a pathological score system. BBB permeability was detected by Evan's blue tracer and BBB tight junction was assessed by brain occludin expression. Immunohistochemistry and real‐time polymerase chain reaction were used to detect MCP‐1 expression in the brain. Nifedipine was used as the antagonist of MCP‐1.
RESULTS: Compared to the control group, change of BBB permeability was more significant in SAP groups, but not in MAP groups. Occludin level decreased 12 h after SAP induction. Pathological score of SAP group was higher than that in MAP group. BBB opening was associated with pancreatic injury. Brain MCP‐1 expression was detected in all the SAP groups, which was correlated with increased BBB permeability, but was not found in the control group or the MAP group. After treatment with nifedipine, brain MCP‐1 level decreased and BBB function improved synchronously in SAP groups.
CONCLUSIONS: BBB permeability increased in SAP significantly and time‐dependently, and was correlated with brain MCP‐1 expression. Nifedipine may improve BBB function by inhibiting MCP‐1 expression. |
doi_str_mv | 10.1111/j.1751-2980.2011.00568.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2688334049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2688334049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4838-65dd5cbde96d6dd9f05477baaf55efb07139b0fad2fbed943e0e106a8012cc933</originalsourceid><addsrcrecordid>eNqNkFFr2zAUhcXYaLquf2EI9mxXsixZLnspTpsVuraMjcFehGRdg1In9iSFJv--cpPmueKCLveecy58CGFKcprexTKnFadZUUuSF4TSnBAuZL79gE6Pi4_Hvipm6HMIy0lUSXGCZkXBuGCUnSJ_vR3BuxWso-7xqNetBx1ddAF7CJs-BuzWqaZxAItNPww2M16nqdHeO_A4BaxAG9e7uJvUXsdwia_wOMQU61KuH3rAQ4d_No8Z_YI-dboPcH74z9Cfm-vfzY_s7mFx21zdZW0pmcwEt5a3xkItrLC27ggvq8po3XEOnSEVZbUhnbZFZ8DWJQMClAgtCS3atmbsDH3b545--L-BENVy2Ph1OqkKISVjJSnrpJJ7VeuHEDx0akw4tN8pStQEWy3VxFFNTNUEW73CVttk_Xo4sDErsEfjG90k-L4XPLsedu8OVs18nppkz_Z2FyJsj3btn5SoWMXV3_uF-rcoH39x2qgb9gKlqJ3N</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2688334049</pqid></control><display><type>article</type><title>Experimental pancreatitis results in increased blood-brain barrier permeability in rats: A potential role of MCP-1</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>DING, Zhen ; LIU, Jun ; LIN, Rong ; HOU, Xiao Hua</creator><creatorcontrib>DING, Zhen ; LIU, Jun ; LIN, Rong ; HOU, Xiao Hua</creatorcontrib><description>OBJECTIVE: To measure the changes of blood‐brain barrier (BBB) permeability in rats with acute pancreatitis (AP) and to investigate the role of monocyte chemoattractant protein (MCP)‐1 expression in this alteration.
METHODS: Rat model of severe acute pancreatitis (SAP) and mild acute pancreatitis (MAP) was induced by pancreatic duct infusion of 5% and 0.5% sodium choleate, respectively, and a saline infusion was used in the control. The severity of AP was evaluated by a pathological score system. BBB permeability was detected by Evan's blue tracer and BBB tight junction was assessed by brain occludin expression. Immunohistochemistry and real‐time polymerase chain reaction were used to detect MCP‐1 expression in the brain. Nifedipine was used as the antagonist of MCP‐1.
RESULTS: Compared to the control group, change of BBB permeability was more significant in SAP groups, but not in MAP groups. Occludin level decreased 12 h after SAP induction. Pathological score of SAP group was higher than that in MAP group. BBB opening was associated with pancreatic injury. Brain MCP‐1 expression was detected in all the SAP groups, which was correlated with increased BBB permeability, but was not found in the control group or the MAP group. After treatment with nifedipine, brain MCP‐1 level decreased and BBB function improved synchronously in SAP groups.
CONCLUSIONS: BBB permeability increased in SAP significantly and time‐dependently, and was correlated with brain MCP‐1 expression. Nifedipine may improve BBB function by inhibiting MCP‐1 expression.</description><identifier>ISSN: 1751-2972</identifier><identifier>EISSN: 1751-2980</identifier><identifier>DOI: 10.1111/j.1751-2980.2011.00568.x</identifier><identifier>PMID: 22356313</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Acute Disease ; acute pancreatitis ; Animals ; Blood-brain barrier ; Blood-Brain Barrier - metabolism ; Blood-Brain Barrier - physiopathology ; Brain injury ; Calcium Channel Blockers - pharmacology ; Chemokine CCL2 - drug effects ; Chemokine CCL2 - metabolism ; Evans Blue - pharmacokinetics ; Immunohistochemistry ; Male ; Membrane permeability ; Membrane Proteins - metabolism ; Monocyte chemoattractant protein ; monocyte chemoattractant protein-1 ; Monocytes ; Nifedipine ; Nifedipine - pharmacology ; Occludin ; Pancreas ; Pancreatitis ; Pancreatitis - chemically induced ; Pancreatitis - pathology ; Pancreatitis - physiopathology ; Permeability ; Permeability - drug effects ; Rats ; Rats, Wistar ; Severity of Illness Index ; Sodium Cholate ; Up-Regulation</subject><ispartof>Journal of digestive diseases, 2012-03, Vol.13 (3), p.179-185</ispartof><rights>2012 The Authors. Journal of Digestive Diseases © 2012 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.</rights><rights>Copyright Wiley Subscription Services, Inc. Mar 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4838-65dd5cbde96d6dd9f05477baaf55efb07139b0fad2fbed943e0e106a8012cc933</citedby><cites>FETCH-LOGICAL-c4838-65dd5cbde96d6dd9f05477baaf55efb07139b0fad2fbed943e0e106a8012cc933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22356313$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DING, Zhen</creatorcontrib><creatorcontrib>LIU, Jun</creatorcontrib><creatorcontrib>LIN, Rong</creatorcontrib><creatorcontrib>HOU, Xiao Hua</creatorcontrib><title>Experimental pancreatitis results in increased blood-brain barrier permeability in rats: A potential role of MCP-1</title><title>Journal of digestive diseases</title><addtitle>J Dig Dis</addtitle><description>OBJECTIVE: To measure the changes of blood‐brain barrier (BBB) permeability in rats with acute pancreatitis (AP) and to investigate the role of monocyte chemoattractant protein (MCP)‐1 expression in this alteration.
METHODS: Rat model of severe acute pancreatitis (SAP) and mild acute pancreatitis (MAP) was induced by pancreatic duct infusion of 5% and 0.5% sodium choleate, respectively, and a saline infusion was used in the control. The severity of AP was evaluated by a pathological score system. BBB permeability was detected by Evan's blue tracer and BBB tight junction was assessed by brain occludin expression. Immunohistochemistry and real‐time polymerase chain reaction were used to detect MCP‐1 expression in the brain. Nifedipine was used as the antagonist of MCP‐1.
RESULTS: Compared to the control group, change of BBB permeability was more significant in SAP groups, but not in MAP groups. Occludin level decreased 12 h after SAP induction. Pathological score of SAP group was higher than that in MAP group. BBB opening was associated with pancreatic injury. Brain MCP‐1 expression was detected in all the SAP groups, which was correlated with increased BBB permeability, but was not found in the control group or the MAP group. After treatment with nifedipine, brain MCP‐1 level decreased and BBB function improved synchronously in SAP groups.
CONCLUSIONS: BBB permeability increased in SAP significantly and time‐dependently, and was correlated with brain MCP‐1 expression. Nifedipine may improve BBB function by inhibiting MCP‐1 expression.</description><subject>Acute Disease</subject><subject>acute pancreatitis</subject><subject>Animals</subject><subject>Blood-brain barrier</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Blood-Brain Barrier - physiopathology</subject><subject>Brain injury</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Chemokine CCL2 - drug effects</subject><subject>Chemokine CCL2 - metabolism</subject><subject>Evans Blue - pharmacokinetics</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Membrane permeability</subject><subject>Membrane Proteins - metabolism</subject><subject>Monocyte chemoattractant protein</subject><subject>monocyte chemoattractant protein-1</subject><subject>Monocytes</subject><subject>Nifedipine</subject><subject>Nifedipine - pharmacology</subject><subject>Occludin</subject><subject>Pancreas</subject><subject>Pancreatitis</subject><subject>Pancreatitis - chemically induced</subject><subject>Pancreatitis - pathology</subject><subject>Pancreatitis - physiopathology</subject><subject>Permeability</subject><subject>Permeability - drug effects</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Severity of Illness Index</subject><subject>Sodium Cholate</subject><subject>Up-Regulation</subject><issn>1751-2972</issn><issn>1751-2980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNkFFr2zAUhcXYaLquf2EI9mxXsixZLnspTpsVuraMjcFehGRdg1In9iSFJv--cpPmueKCLveecy58CGFKcprexTKnFadZUUuSF4TSnBAuZL79gE6Pi4_Hvipm6HMIy0lUSXGCZkXBuGCUnSJ_vR3BuxWso-7xqNetBx1ddAF7CJs-BuzWqaZxAItNPww2M16nqdHeO_A4BaxAG9e7uJvUXsdwia_wOMQU61KuH3rAQ4d_No8Z_YI-dboPcH74z9Cfm-vfzY_s7mFx21zdZW0pmcwEt5a3xkItrLC27ggvq8po3XEOnSEVZbUhnbZFZ8DWJQMClAgtCS3atmbsDH3b545--L-BENVy2Ph1OqkKISVjJSnrpJJ7VeuHEDx0akw4tN8pStQEWy3VxFFNTNUEW73CVttk_Xo4sDErsEfjG90k-L4XPLsedu8OVs18nppkz_Z2FyJsj3btn5SoWMXV3_uF-rcoH39x2qgb9gKlqJ3N</recordid><startdate>201203</startdate><enddate>201203</enddate><creator>DING, Zhen</creator><creator>LIU, Jun</creator><creator>LIN, Rong</creator><creator>HOU, Xiao Hua</creator><general>Blackwell Publishing Asia</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>201203</creationdate><title>Experimental pancreatitis results in increased blood-brain barrier permeability in rats: A potential role of MCP-1</title><author>DING, Zhen ; LIU, Jun ; LIN, Rong ; HOU, Xiao Hua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4838-65dd5cbde96d6dd9f05477baaf55efb07139b0fad2fbed943e0e106a8012cc933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute Disease</topic><topic>acute pancreatitis</topic><topic>Animals</topic><topic>Blood-brain barrier</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Blood-Brain Barrier - physiopathology</topic><topic>Brain injury</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Chemokine CCL2 - drug effects</topic><topic>Chemokine CCL2 - metabolism</topic><topic>Evans Blue - pharmacokinetics</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Membrane permeability</topic><topic>Membrane Proteins - metabolism</topic><topic>Monocyte chemoattractant protein</topic><topic>monocyte chemoattractant protein-1</topic><topic>Monocytes</topic><topic>Nifedipine</topic><topic>Nifedipine - pharmacology</topic><topic>Occludin</topic><topic>Pancreas</topic><topic>Pancreatitis</topic><topic>Pancreatitis - chemically induced</topic><topic>Pancreatitis - pathology</topic><topic>Pancreatitis - physiopathology</topic><topic>Permeability</topic><topic>Permeability - drug effects</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Severity of Illness Index</topic><topic>Sodium Cholate</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DING, Zhen</creatorcontrib><creatorcontrib>LIU, Jun</creatorcontrib><creatorcontrib>LIN, Rong</creatorcontrib><creatorcontrib>HOU, Xiao Hua</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Journal of digestive diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DING, Zhen</au><au>LIU, Jun</au><au>LIN, Rong</au><au>HOU, Xiao Hua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experimental pancreatitis results in increased blood-brain barrier permeability in rats: A potential role of MCP-1</atitle><jtitle>Journal of digestive diseases</jtitle><addtitle>J Dig Dis</addtitle><date>2012-03</date><risdate>2012</risdate><volume>13</volume><issue>3</issue><spage>179</spage><epage>185</epage><pages>179-185</pages><issn>1751-2972</issn><eissn>1751-2980</eissn><abstract>OBJECTIVE: To measure the changes of blood‐brain barrier (BBB) permeability in rats with acute pancreatitis (AP) and to investigate the role of monocyte chemoattractant protein (MCP)‐1 expression in this alteration.
METHODS: Rat model of severe acute pancreatitis (SAP) and mild acute pancreatitis (MAP) was induced by pancreatic duct infusion of 5% and 0.5% sodium choleate, respectively, and a saline infusion was used in the control. The severity of AP was evaluated by a pathological score system. BBB permeability was detected by Evan's blue tracer and BBB tight junction was assessed by brain occludin expression. Immunohistochemistry and real‐time polymerase chain reaction were used to detect MCP‐1 expression in the brain. Nifedipine was used as the antagonist of MCP‐1.
RESULTS: Compared to the control group, change of BBB permeability was more significant in SAP groups, but not in MAP groups. Occludin level decreased 12 h after SAP induction. Pathological score of SAP group was higher than that in MAP group. BBB opening was associated with pancreatic injury. Brain MCP‐1 expression was detected in all the SAP groups, which was correlated with increased BBB permeability, but was not found in the control group or the MAP group. After treatment with nifedipine, brain MCP‐1 level decreased and BBB function improved synchronously in SAP groups.
CONCLUSIONS: BBB permeability increased in SAP significantly and time‐dependently, and was correlated with brain MCP‐1 expression. Nifedipine may improve BBB function by inhibiting MCP‐1 expression.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>22356313</pmid><doi>10.1111/j.1751-2980.2011.00568.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1751-2972 |
ispartof | Journal of digestive diseases, 2012-03, Vol.13 (3), p.179-185 |
issn | 1751-2972 1751-2980 |
language | eng |
recordid | cdi_proquest_journals_2688334049 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Acute Disease acute pancreatitis Animals Blood-brain barrier Blood-Brain Barrier - metabolism Blood-Brain Barrier - physiopathology Brain injury Calcium Channel Blockers - pharmacology Chemokine CCL2 - drug effects Chemokine CCL2 - metabolism Evans Blue - pharmacokinetics Immunohistochemistry Male Membrane permeability Membrane Proteins - metabolism Monocyte chemoattractant protein monocyte chemoattractant protein-1 Monocytes Nifedipine Nifedipine - pharmacology Occludin Pancreas Pancreatitis Pancreatitis - chemically induced Pancreatitis - pathology Pancreatitis - physiopathology Permeability Permeability - drug effects Rats Rats, Wistar Severity of Illness Index Sodium Cholate Up-Regulation |
title | Experimental pancreatitis results in increased blood-brain barrier permeability in rats: A potential role of MCP-1 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T16%3A20%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experimental%20pancreatitis%20results%20in%20increased%20blood-brain%20barrier%20permeability%20in%20rats:%20A%20potential%20role%20of%20MCP-1&rft.jtitle=Journal%20of%20digestive%20diseases&rft.au=DING,%20Zhen&rft.date=2012-03&rft.volume=13&rft.issue=3&rft.spage=179&rft.epage=185&rft.pages=179-185&rft.issn=1751-2972&rft.eissn=1751-2980&rft_id=info:doi/10.1111/j.1751-2980.2011.00568.x&rft_dat=%3Cproquest_cross%3E2688334049%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4838-65dd5cbde96d6dd9f05477baaf55efb07139b0fad2fbed943e0e106a8012cc933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2688334049&rft_id=info:pmid/22356313&rfr_iscdi=true |